Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DMI4OTW)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Alphaxalone; Alfaxalone; 23930-19-0; 5alpha-Pregnan-3alpha-ol-11,20-dione; GR 2/234; Alfaxalonum [INN-Latin]; Alfaxalona [INN-Spanish]; 3alpha-Hydroxy-5alpha-pregnane-11,20-dione; UNII-BD07M97B2A; BRN 3217240; MLS001076262; MLS000069684; 3alpha-Hydroxy-5alpha-pregnan-11,20-dion; BD07M97B2A; CHEMBL190279; CHEBI:34531; 3-alpha-Hydroxy-5-alpha-pregnane-11,20-dione; (3-alpha,5-alpha)-3-Hydroxypregnane-11,20-dione; alfaxolone; 3-Hydroxypregnane-11,20-dione; NCGC00023100-03; SMR000058494; (3a,5a)-3-Hydroxypregnane-11,20-dione
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
Molecule-Related Drug Atlas
Molecule Type:
DTT Drug Status:
Approved Drug(s) Clinical Trial Drug(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug(s) Targeting Gamma-aminobutyric acid receptor (GAR)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Molecular Interaction Atlas | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
References